Vienna, May 15, 2009



  • Revenue decreased by 7.9% to EUR 146.9 million
  • EBT at EUR 14.5 million achieved previous year’s level
  • Outlook clouded for 2009 as a whole

Vienna, May 15, 2009 – The business development of the Semperit Group in the first quarter 2009 was satisfactory in the light of the extremely difficult business environment.

1-3/2008 1-3/2009 Change in %
Revenue in EUR million 159.5 146.9 -7.9
EBIT in EUR million 16.3 14.0 -14.0
EBT in EUR million 14.5 14.5 -0,1

In the first three quarters of 2009, total revenue amounted to EUR 146.9 million (previous year: EUR 159.5 million). Due to declining raw material costs, productivity improvements and an improvement in the financial result earnings before tax were at a good level, totalling EUR 14.5 million (previous year: EUR 14.5 million). Higher minority interests led to a decrease in the consolidated net profit for the period to EUR 7.8 million (previous year: EUR 10.5 million).


The Sempermed segment reported a 18.9% increase in revenue in the first quarter 2009, to EUR 67.4 million, expanding even more strongly than the overall market. Earnings before tax (EBT) of the Sempermed segment improved to EUR 7.8 million (previous year: EUR 3.6 million), which can be attributed to a series of successfully implemented measures designed to raise efficiency.

Total revenue of the Semperflex segment declined by 33.6% in the first three months of 2009, to EUR 28.5 million, based on weak demand in all segments and in all sales markets. Accordingly, earnings before tax fell to EUR 1.5 million (previous year: EUR 5.2 million).

Total revenue of the Semperform segment amounted to EUR 22.8 million in the first quarter of 2009, a decline of 18.1%. All segments were negatively impacted by the economic crisis, though to varying extents. Earnings before tax fell by 56.2% year-on-year, to EUR 1.6 million.

The Sempertrans segment registered a revenue decrease of 11.8% to EUR 28.2 million. Earnings before tax were above the preceding year’s level, totalling EUR 4.1 million (previous year: EUR 4.0 million).


Due to the difficult economic conditions, business in all segments in which Semperit operates is expected to decline, with the exception of the Sempermed segment. Nevertheless, Semperit aims to cushion the revenue decrease by increasing its market shares. On the earnings side, Semperit is working to achieve further process optimisation and cost saving. Investments in existing facilities as a means of furthering increasing efficiency are designed to strengthen Semperit’s overall competitive position.

Please direct any inquiries to:

Semperit AG Holding
Investor Relations
Sybille Bernhardt
Tel.: +43 (1) 79 777-210


Monika Riedel
Director Group Brand Management, Corporate Spokesperson
T +43 1 79777-620